Poster Presentations
Friday, October 12, 2018
Adjuvant endocrine therapy | |
P01 | ANTI-HORMONAL THERAPY ALONE IN N1 STAGE BREAST CANCER PATIENTS WITH HORMONE RECEPTOR POSITIVE AND HER-2 NEGATIVE Sung-Ui Jung, South Korea |
P02 | MALE BREAST CANCER IN AUSTRALIA: COMPLIANCE WITH TREATMENT KEY PERFORMANCE INDICATORS – 99,768 BREAST CANCERS OVER A 10 YEAR PERIOD Chris Lomma, Australia |
P03 | SYSTEMIC ADJUVANT TREATMENT RECOMMENDATIONS AND COMPLIANCE IN AUSTRALIAN PATIENTS WITH EARLY BREAST CANCER Chris Lomma, Australia |
Bone health | |
P04 | PERCUTANEOUS PEDICLE SCREW FIXATION FOLLOWED BY CEMENTOPLASTY: A MINIMALLY INVASIVE TECHNIQUE FOR SPINAL METASTASIS IN BREAST CANCER PATIENTS Claudio Pusceddu, Italy |
Breast cancer genetics | |
P05 | PREVALENCE OF OESTROGEN RECEPTOR POSITIVE BREAST CANCER IN OBESITY PATIENTS: A RETROSPECTIVE STUDY Nur Aziah Binti Adib Anuar, Malaysia |
P06 | LVI IS IT MORE WORSE PREDICT OUTCOME THAN WE BELIEVE WE KNOW ABOUT IT? SYSTEMIC REVIEW OF SINGLE INSTITUTE IN SAUDI ARABIA Abdulaziz Alhamad, Saudi Arabia |
P07 | METHYLATION STATUS OF MGMT AND MEG3 GENE’S PROMOTERS IN TRIPLE – NEGATIVE BREAST CANCER Sylwia Sloniec, Poland |
Breast imaging | |
P08 | FEATURE OF THE BREAST LESION CAN BE DECEPTIVE: MIMICKERS OF BREAST MALIGNANCY Visnja Baksa Reynolds, Singapore |
P09 | SHEAR WAVE ULTRASOUND AND HIGH MAMMOGRAPHIC BREAST DENSITY (HMBD); A PILOT STUDY OF BREAST STIFFNESS REDUCTION IN PRE-MENOPAUSAL WOMEN WITH HMBD Stephen Birrell, Australia |
P10 | LITERATURE REVIEW AND CASE REPORT OF GRANULAR CELL TUMOUR IN BREAST Amy Cao, Australia |
P11 | THE IMPACT OF PRE-OPERATIVE MRI IN THE MANAGEMENT OF INVASIVE LOBULAR CARCINOMA OF THE BREAST Jennifer Chang, New Zealand |
P12 | KEEP CALM, IT`S JUST `MOOBS` Mei Chan Chin, Australia |
P13 | THE BRILLIANCE OF CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) Laurence Gluch, Australia |
P14 | COMPARISON OF USEFULNESS OF ULTRASOUND AND MRI FOR DIAGNOSIS OF SILICON BREAST IMPLANT RUPTURE Naoya Gomi, Japan |
P15 | FEATURES OF IMAGE FINDINGS OF DIGITAL BREAST TOMOSYNTHESIS (DBT) UNDETECTED BREAST CANCER Mari Kikuchi, Japan |
P16 | APPROACHING BREAST IMPLANT ASSOCIATED COMPLICATION WITH ULTRASOUND AND CHECKLIST Angela Soeun Lee, South Korea |
P17 | SQUAMOUS CELL METAPLASIA OF LACTIFEROUS DUCTS IN MALE PATIENTS Rachael Manning, Australia |
P18 | WHICH IS THE BETTER METHOD TO DETECT ABNORMALITIES BY VISUAL ESTIMATE OR VOLPARA FOR WOMEN WITH DENSE BREAST? Misaki Matsuyanagi, Japan |
P19 | FALSE NEGATIVE ON COMPUTER-AIDED DETECTION APPLICATION IN PREOPERATIVE AUTOMATED BREAST ULTRASOUND OF BREAST CANCER PATIENTS Jiwon Rim, South Korea |
P20 | IMPACT OF PRE-OPERATIVE BREAST MRI ON BREAST CANCER TREATMENT PLANNING Masuma Sarker, UK |
P21 | THE BREAST CANCER RELATED-RISKS IN WOMEN WITH DENSE BREAST TISSUE IS CLARIFIED BY USING VOLPARATM Terumasa Sawada, Japan |
P22 | DIAGNOSTIC VALIDITY OF SURGEON-PERFORMED BREAST ULTRASOUND FOR FEMALES WITH PALPABLE BREAST MASSES Apple Valparaiso, Philippines |
P23 | THE DIFFERENTIAL DIAGNOSIS OF THE BREAST FINDINGS USING AUTOMATED BREAST VOLUME SCANNER (ABVS) AND ADVANCED ELASTOGRAPHY Mihaela Vancu, Romania |
P24 | INFLUENCE OF PRE-OPERATIVE BREAST CANCER LOCALIZATION TECHNIQUES ON RATES OF SENTINEL LYMPH NODE VISUALIZATION WITH PREOPERATIVE LYMPHOSCINTIGRAPHY Shipra Verma, Australia |
Breast reconstruction | |
P25 | PREPECTORAL IMMEDIATE IMPLANT-BASED RECONSTRUCTION USING BRAXON: AN ACELLULAR DERMAL MATRIX – NATIONAL AUDIT FROM THE UNITED KINGDOM Dayalan Clarke, UK |
Endocrine resistance | |
P26 | RIBOCICLIB + FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR+), HER2-NEGATIVE (HER2–) ADVANCED BREAST CANCER (ABC): RESULTS FROM MONALEESA-3 Arlene Chan, Australia |
P27 | SINGLE CENTER STUDY IN THE PHILIPPINES ON ERIBULIN MESYLATE IN METASTATIC BREAST CANCER FROM 2013-2016 Amabelle Trina Gerona, Philippines |
Molecular assays | |
P28 | OPTIMA: A PROSPECTIVE RANDOMISED TRIAL TO VALIDATE THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF GENE EXPRESSION TEST-GUIDED CHEMOTHERAPY DECISIONS IN HIGH CLINICAL RISK EARLY BREAST CANCER Janet Dunn, UK |
P29 | TUMOR MICROENVIRONMENT AND ITS PHARMACOLOGICAL MODULATION IN A BREAST CANCER MODEL: PARALLELS TO SKIN WOUND HEALING Peter Gal, Slovakia |
P30 | EXPLORING IN VITRO ANDROGEN BIOASSAYS AS A CLINICAL TOOL FOR BREAST CANCER Rachel Lund, New Zealand |
Neoadjuvant therapy | |
P31 | PATHOLOGIC OUTCOMES OF HER2 POSITIVE NON METASTATIC BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT DUAL ANTI HER2 THERAPY AND TAXANE AT SYDNEY ADVENTIST HOSPITAL (SAH) Joseph Do Woong Choi, Australia |
P32 | DESIGN OF PERSIA: PERTUZUMAB STUDY FOR HER2-POSITIVE NON-METASTATIC BREAST CANCER IN THE NEOADJUVANT SETTING IN AUSTRALIA Richard De Boer, Australia |
P33 | PREDICTIVE FACTORS OF STABLE OR PROGRESSIVE DISEASE DURING ANTHRACYCLINE WITH/WITHOUT TAXANE-BASED NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER Ji Young Kim, South Korea |
Prevention | |
P34 | EARLY-LIFE BODY FATNESS IN RELATION TO TEXTURE VARIATION ON A MAMMOGRAM Hannah Oh, South Korea |
P35 | COMPLIANCE WITH MULTIDISCIPLINARY TEAM MEETING TREATMENT RECOMMENDATIONS Amali Samarasinghe, Australia |
Radiotherapy | |
P36 | DOES THE TUMOR BED SURGICAL CLIPS AFFECT DOSIMETRIC CHANGES IN THREE – DIMENSIONAL FIELD-IN-FIELD WHOLE-BREAST IRRADIATION TECHNIQUES FOR PATIENTS UNDERGOING BREAST CONSERVING SURGERY? Dong Soo Lee, South Korea |
Supportive care | |
P37 | IMAGING-PROVEN VENOUS THROMBOEMBOLISM AMONG BREAST CANCER PATIENTS IN A TERTIARY HOSPITAL IN THE PHILIPPINES FROM 2010-2015 Amabelle Trina Gerona, Philippines |
P38 | THE EFFICACY OF BILASTINE FOR TAXANE REGIMENS INDUCED RASH Taizo Hirata, Japan |
P39 | FEASIBILITY OF SEGMENTAL ECW/TBW RATIO FOR MILD TO MODERATE DEGREE BREAST CANCER-RELATED LYMPHEMDEMA: CORRELATION WITH TAPE CIRCUMFERENTIAL VOLUME MEASUREMENT Woo Gyeong Kim, South Korea |
P40 | CONSENT IN THE AGE OF WHITAKER AND MONTGOMERY: TIPTOEING THROUGH THE MINEFIELD OF PATIENT AUTONOMY Mona Tan, Singapore |
Survivorship | |
P41 | LYMPHATIC MICROSURGICAL PREVENTING HEALING APPROACH (LYMPHA): A SYSTEMATIC REVIEW Natalia Garibotto, Australia |
P42 | PLEOMORPHIC LOBULAR BREAST CANCER: DOES MORPHOLOGY MATTER? Laurence Gluch, Australia |
P43 | ETHNIC DISPARITIES IN THE INCIDENCE OF PHYLLODES TUMOURS AT COUNTIES MANUKAU HEALTH Megan Grinlinton, New Zealand |
P44 | UTILITY OF SERUM TUMOUR MARKER VELOCITY OF CANCER ANTIGEN 15-3 (CA15-3) AND CARCINOEMBRYONIC ANTIGEN (CEA) IN BREAST CANCER SURVEILLANCE Jun Xian Hing, Singapore |
P45 | TREATMENT PATTERNS AND CLINICAL OUTCOMES IN ELDERLY BREAST CANCER PATIENTS Eunyoung Kang, South Korea |
P46 | IMPACT OF VITAMIN D ON BREAST CANCER OUTCOME Trisha Khoo, Australia |
P47 | OLIGOMETASTATIC BREAST CANCER: CAN WE EVER SAY CURE? Tahlia Molinaro, Australia |
P48 | QUALITY OF LIFE AND BODY IMAGE IN WOMEN WITH SURGERY FOR BREAST CANCER IN SINGAPORE Siau Wei Tang, Singapore |
P49 | ESTABLISHING ROUTINE COLLECTION OF PATIENT-REPORTED OUTCOMES VIA THE BREASTSURGANZ QUALITY AUDIT: A PROOF-OF-PRINCIPLE PROJECT TO TEST FEASIBILITY David Walters, Australia |
P50 | BREAST CANCER FOLLOW-UP: THE PATIENTS PERSPECTIVE Maggie Wilcox, UK |
P51 | PHYSIOTHERAPY MANAGEMENT OF BREAST CANCER TREATMENT-RELATED FATIGUE, LYMPHOEDEMA, METASTATIC AND RADIATION-INDUCED BRACHIAL PLEXOPATHY: A CASE REPORT Wai Yeung, Australia |
P52 | WALKING THE BOUNDARIES: IS THE 6-MINUTE WALK TEST ACHIEVABLE IN AN OUTPATIENT BREAST CLINIC? Lei Ying, Australia |
Triple negative breast cancer | |
P53 | HEALTH CARE RESOURCE UTILIZATION FOR PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (mTNBC) IN THE REAL WORLD CLINICAL SETTING: AN OBSERVATIONAL BREAST CANCER (OBTAIN) STUDY FROM AUSTRALIA Elani Bowers, Australia |
P54 | THE MANAGEMENT OF BRCA PATIENTS IN THE WELLINGTON REGION: A 10 YEAR OVERVIEW Sue Hui Ong, New Zealand |
P55 | RADIOGENOMIC ANALYSIS OF TRIPLE NEGATIVE BREAST CANCER: FEATURES OF RADIOMICS AND TRANSCRIPTOMICS Sung Ui Shin, South Korea |
Saturday, October 13, 2018
Breast cancer screening | |
P01 | LOBULAR NEOPLASIA IN BREAST SCREEN SETTING MULTICENTRE STUDY (ST VINCENT AND MONASH) RETROSPECTIVE, DESCRIPTIVE STUDY: 23 YEARS (1993-2016) Parisa Aminzadeh, Australia |
P02 | ZnR/GPR39 MODULATES KCC ACTIVITY IN ESTROGEN NEGATIVE BREAST CANCER CELLS Moumita Chakraborty, Israel |
P03 | ROS-MEDIATED APOPTOSIS INDUCED BY FRUIT POLYPHENOLS IS FOLLOWED BY P38MAPK, ERK1/2 AND THE AKT SIGNALING PATHWAYS MODULATION IN BREAST CARCINOMA MODEL Matus Coma, Slovakia |
P04 | IS ASYMPTOMATIC SURVEILLANCE AFTER STANDARD TREATMENT BENEFICIAL?: A 10 YR-SURVIVAL ANALYSIS OF RECURRENT BREAST CANCER PATIENTS BY DETECTION METHOD OF RECURRENCE Han Shin Lee, South Korea |
P05 | OPTIMISING THE EARLY DETECTION OF BREAST CANCER IN AUSTRALIA Carolyn Nickson, Australia |
P06 | USING THE GAIL MODEL TO RISK-STRATIFY WOMEN FOR BREAST CANCER SCREENING: MODEL VALIDATION ON 40,000 AUSTRALIAN WOMEN ATTENDING BREASTSCREEN Carolyn Nickson, Australia |
P07 | SOME OPTIONS FOR COMBINING QUESTIONNAIRE AND MAMMOGRAPHIC DENSITY MEASURES TO ESTIMATE RISK OF FUTURE INVASIVE BREAST CANCER AND INTERVAL CANCERS IN SCREENED WOMEN Carolyn Nickson, Australia |
P08 | MACHINE LEARNING MODELS FOR POPULATION-LEVEL RISK STRATIFICATION Pietro Procopio, Australia |
P09 | RELIABILITY OF SUSPICION OF MALIGNANT BREAST MASS IN AUTOMATED BREAST ULTRASOUND (ABUS) EXAMINATION: AUTOMATED VERSUS HANDHELD BREAST ULTRASOUND Jiwon Rim, South Korea |
Breast reconstruction | |
P10 | SCARLESS LATISSIMUS DORSI FLAP: AN EXCELLENT OPTION FOR LOWER POLE COVER IN IMPLANT BASED RECONSTRUCTION FOR A CHALLENGING SUBSET OF PATIENTS Vanitha Budhavaram, Australia |
P11 | SINGLE PORT LAPAROSCOPIC HARVESTED OMENTAL FLAP FOR IMMEDIATE BREAST RECONSTRUCTION: EXPERIENCE IN SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL Sumin Chae, South Korea |
P12 | DOES IMMEDIATE BREAST RECONSTRUCTION LEAD TO A DELAY IN ADJUVANT CHEMOTHERAPY FOR BREAST CANCER?: A META-ANALYSIS AND SYSTEMATIC REVIEW Patrick Cook, Australia |
P13 | BREAST RECONSTRUCTION IN THE REGIONAL SETTING: 5 YEARS OF EXPERIENCE Daniel Keating, Australia |
P14 | CLINICAL AUDIT REDUCTION MAMMOPLASTY FROM 2011 TO 2016: AN ASSESSMENT OF SURGICAL OUTCOME AND WAITING PERIOD IN A TERTIARY PUBLIC HOSPITAL Jeffrey Smith, Australia |
DCIS | |
P15 | ACTIVE MONITORING VERSUS IMMEDIATE TREATMENT FOR WOMEN WITH LOCALISED, LOW-RISK DUCTAL CARCINOMA IN SITU: DOES IT MAKE ECONOMIC SENSE? Hannah Bromley, Australia |
P16 | TRIPLE NEGATIVE DCIS Sayuka Nakayama, Japan |
Local therapy | |
P17 | RADIO-GUIDED OCCULT LESION LOCALISATION USING IODINE-125 SEEDS (ROLLIS) IS A SAFE ALTERNATIVE TO HOOK-WIRE LOCALISATION (HWL) Brenno Becker, Australia |
P18 | THE USE OF WIRELESS TECHNOLOGY IN BREAST CANCER: HOW TO START YOUR OWN RADIOGUIDED OCCULT LESION LOCALISATION PROGRAMME USING IODINE – 125 SEEDS (ROLLIS) Brenno Becker, Australia |
P19 | CLINICOPATHOLOGIC PROFILE AND OUTCOMES OF PHYLLODES TUMOR OF THE BREAST: A 10-YEAR REVIEW OF A PHILIPPINE TERTIARY HOSPITAL EXPERIENCE Shiela Macalindong, Philippines |
P20 | CAN METHYLENE BLUE DYE BE USED AS AN ALTERNATIVE TO PATENT BLUE DYE TO FIND THE SENTINEL LYMPH NODE IN BREAST CANCER SURGERY? Omid Rouhbakhshfar, Iran |
P21 | MUCINOUS BREAST CARCINOMA. A SINGLE INSTITUTION EXPERIENCE Nikolaos Salemis, Greece |
P22 | OPTIMAL TREATMENT MODALITY OF PSEUDOANGIOMATOUS STROMAL HYPERPLASIA OF THE BREAST Kwanghyun Yoon, South Korea |
Locoregional therapy | |
P23 | LITERATURE REVIEW AND THREE CASE REPORTS OF BREAST FIBROMATOSIS: A MASQUERADE OF BREAST CANCER Amy Cao, Australia |
P24 | A NOVEL PREDICTIVE TOOL FOR HEAVY AXILLARY NODAL INVOLVEMENT IN SENTINEL NODE POSITIVE BREAST CANCER Nipu Jayatilleke, Australia |
P25 | MAGNETIC TRACER USE FOR SENTINEL NODE BIOPSY: INTRODUCTION TO AN AUSTRALASIAN PILOT STUDY Ahrin Anna Morrow, New Zealand |
P26 | IMPACT OF THE AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP Z0011 TRIAL ON THE MANAGEMENT OF POSITIVE AXILLARY NODES IN THE AUSTRALIAN SETTING Nicholas K. Ngui, Australia |
P27 | OUTCOMES OF RIB RESECTION FOR BREAST TUMORS EXTENDING TO THE CHEST WALL Kristine Paguirigan, Philippines |
P28 | DISCUSSION ON INDICATIONS OF INTERNAL MAMMARY SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER IN THE ERA OF PRECISION MEDICINE Peng-Fei Qiu, China |
P29 | A PROSPECTIVE COMPARATIVE DOUBLE ARM STUDY OF SLNB WITH ICG BASED TECHNIQUE VERSUS COMBINATION DUAL DYE TECHNIQUE FOR EARLY BREAST CANCER: FIRST INDIAN STUDY S.P. Somashekhar, India |
P30 | THE ‘TWINKLE’ ARTEFACT: A NOVEL METHOD OF CLIP IDENTIFICATION TO FACILITATE TARGETED AXILLARY SURGERY FOLLOWING NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS Mona Tan, Singapore |
P31 | INDOCYANINE GREEN FLUORESCENCE VERSUS BLUE DYE OR RADIOISOTOPE FOR DETECTION RATE OF SENTINEL LYMPH NODE BIOPSY AND NODES REMOVED IN BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Sarun Thongvitokomarn, Thailand |
P32 | BREAST CANCER ANATOMIC STAGING WITH RISK SCORE IS SIMPLE TO USE AND EFFECTIVE Ru Xin Wong, Singapore |
Oncoplastic surgery | |
P33 | PERFORATOR FLAPS FOR BREAST CONSERVING SURGERY: RESULTS FROM AN EARLY SERIES Nita Bartlett, Australia |
P34 | IMAGING RESULTS FOLLOWING PARTIAL BREAST RECONSTRUCTION WITH CHEST WALL PERFORATOR FLAPS: A QUALITATIVE ANALYSIS WHEN COMPARED TO STANDARD BREAST CONSERVING SURGERY Jesse Hu, Singapore |
P35 | PREOPERATIVE 3D PRINTING TO AID PLANNING IN COMPLEX BREAST PROCEDURES Railya Mousina, Australia |
P36 | DOES ONCOPLASTIC SURGERY HAVE A ROLE IN OPTIMISING BREAST CONSERVATION TREATMENT IN AN ASIAN CONTEXT?Mona Tan, Singapore |
P37 | EFFICACY AND SAFETY OF TRANEXAMIC ACID IN ONCOPLASTIC BREAST SURGERY: A SYSTEMATIC LITERATURE REVIEW Kartik Vasan, Australia |
P38 | PRACTICE PATTERNS OF ANTIBIOTIC PROPHYLAXIS IN ONCOPLASTIC BREAST SURGERY: A NATIONWIDE AUSTRALIAN SURVEY Kartik Vasan, Australia |
Radiotherapy | |
P39 | ACCELERATED PARTIAL BREAST IRRADIATION (APBI) WITH EXTRACRANIAL STEREOTACTIC RADIOTHERAPY (SBRT) AND EXACTRAC ADAPTIVE GATING IN LOW-RISK EARLY BREAST CANCER: 5-YEAR FOLLOW-UP Angel Acosta Rojas, Spain |
P40 | POST-MASTECTOMY HYPOFRACTIONATED LOCOREGIONAL IRRADIATION (HLRI) Angel Acosta Rojas, Spain |
P41 | HYPOFRACTIONATED RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER AFTER CONSERVATIVE SURGERY Angel Acosta Rojas, Spain |
P42 | HYPOFRACTIONATED ACCELERATED RADIOTHERAPY FOR DUCTAL CARCINOMA IN SITU (DCIS) Angel Acosta Rojas, Spain |
P43 | INTRAOPERATIVE RADIOTHERAPY FOR EARLY STAGE BREAST CANCER AT THE MONASH CANCER CENTRE: FEASIBILITY AND ACUTE TOXICITY Steven David, Australia |
P44 | DEVELOPMENT OF A TREATMENT TECHNIQUE FOR THE AEROFORM™ TISSUE EXPANDER BREAST IMPLANT SYSTEM: A SINGLE DEPARTMENT EXPERIENCE Jennie Gilliman, Australia |
P45 | EVALUATION OF SETUP ACCURACY FOR PRONE BREAST RADIOTHERAPY WITH A 3D SURFACE IMAGING SYSTEM Sunmi Jo, South Korea |
P46 | DEEP INSPIRATION BREATH HOLD COMPLIANCE RATE AT SIMULATION AT GENESISCARE VICTORIA Cynleen Kai, Australia |
P47 | COMPARING EVIDENCE-BASED RECOMMENDATIONS FOR RADIOTHERAPY USE AGAINST ROUTINE PRACTICE IN BREAST CANCER Roya Merie, Australia |
P48 | UTILITY OF DEEP INSPIRATORY BREATH HOLD (DIBH) IN THE RADIOTHERAPEUTIC MANAGEMENT OF RIGHT SIDED BREAST CANCER Andrew See, Australia |
P49 | PARADIGMS IN BREAST CANCER MANAGEMENT IN PREVIOUSLY AUGMENTED BREASTS: TIME FOR A CHANGE? Kartik Vasan, Australia |
Molecular assays | |
P50 | NETRIN-1 EXPRESSION IN BREAST CANCER Shyr-Ming Sheen-Chen, Taiwan |